Article

Validation of a multi-gene qPCR-based pharmacogenomics panel across major ethnic groups in Singapore and Indonesia

2021-05-11

Abstract excerpt

<h4>Background</h4> With up to 70% of adverse drug reactions (ADRs) having high genetic associations, the clinical utility of pharmacogenomics (PGx) has been gaining traction. Nala PGx Core™ is a multi-gene qPCR-based panel that comprises 18 variants and 2 CYP2D6 Copy Number markers across 4 pharmacogenes – CYP2C9, CYP2C19, CYP2D6 and SLCO1B1 . <h4>Objectives</h4> In this study, we validated the performance of Nal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4b467ca4-4203-5a3f-8cca-8c9b38745abc
DOI: 10.1101/2021.05.10.21256948

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validation of a multi-gene qPCR-based pharmacogenomics panel across major ethnic groups in Singapore and IndonesiaDOI 10.1101/2021.05.10.21256948Read

Validation of a multi-gene qPCR-based pharmacogenomics panel across major ethnic groups in Singapore and Indonesia.Semantic proximity Read

Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation.Semantic proximity Read

Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse PopulationsSemantic proximity Read

Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.Semantic proximity Read

CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.Semantic proximity Read

The variation landscape of CYP2D6 in a multi-ethnic Asian population.Semantic proximity Read

The variation landscape of <i>CYP2D6</i> in a multi-ethnic Asian populationSemantic proximity Read

Comparative evaluation of genotyping and low-pass sequencing for pharmacogenetic variant and phenotype inferenceSemantic proximity Read

Allele, Diplotype, and Phenotype Frequency Distribution of CYP2B6, CYP2C19, and CYP2D6 in the Han Population in North China.Semantic proximity Read

Complete pharmacogenomic profile from exome sequencingSemantic proximity Read

Comparison of genome sequencing and clinical genotyping for pharmacogenesSemantic proximity Read

DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.Semantic proximity Read